129 results on '"Bagot, Catherine"'
Search Results
2. Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial
3. Post-COVID-19 illness and associations with sex and gender
4. Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial
5. Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy
6. A multisystem, cardio-renal investigation of post-COVID-19 illness
7. The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1
8. The bleeding phenotype in people with nonsevere hemophilia
9. Seroprevalence to adeno‐associated virus type 6 in people with hemophilia B from a UK adult cohort
10. Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort
11. Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.
12. Long COVID and cardiovascular disease: a prospective cohort study.
13. Outcomes of total hip and knee arthroplasty in patients with haemophilia: A meta‐analysis of comparative studies and clinical practice recommendations.
14. A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B.
15. Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study.
16. An investigation of the role of maternal hoxiao in embryonic implantation
17. Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis
18. Chapter 41 - Hemostasis and Thrombosis
19. Catastrophic venous and arterial thrombosis in a young female with cervical cancer.
20. Women with unexplained recurrent pregnancy loss do not have evidence of an underlying prothrombotic state: Experience with calibrated automated thrombography and rotational thromboelastometry
21. A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists
22. Thrombopoietin mimetic‐induced bone marrow fibrosis.
23. Correlating prothrombin time with plasma rivaroxaban level
24. List of Contributors
25. Rivaroxaban (Xarelto) in the management of stroke and DVT
26. Deep vein thrombosis: diagnosis, prevention and treatment
27. Chapter 41 - Hemostasis and Thrombosis
28. Is ‘Virchowʼs triad’ useful? – response to Malone and Agutter
29. Late onset hypogonadism: an alternate cause for night sweats in the haematology clinic
30. Virchow and his triad: a question of attribution
31. Imatinib Mesylate as a Cause of Acute Liver Failure
32. European principles of care for women and girls with inherited bleeding disorders.
33. Direct Regulation of β3-Integrin Subunit Gene Expression by HOXA10 in Endometrial Cells
34. Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: First Results from a Phase 3 Study to Evaluate Efficacy and Safety in People with Hemophilia a or B without Inhibitors (ATLAS-A/B)
35. The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study.
36. Managing venous thromboembolic risk in women undergoing spontaneous or induced early pregnancy loss: a consensus statement from the British Society of Haematology Obstetric Haematology Special Interest Group.
37. History of the West of Scotland Haemophilia Centre, Glasgow, 1950–2019.
38. Helen Cotton.
39. The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper.
40. Severe antithrombin deficiency in pregnancy: Achieving adequate anticoagulation.
41. Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial.
42. Chapter 7 - Hemostasis and Thrombosis
43. List of Contributors
44. Real World Use of Thrombopoietin-Receptor Agonists in the Management of Immune Thrombocytopenia in the United Kingdom: Results from the TRAIT Study
45. Prevention and treatment of venous thromboembolic disease.
46. Autologous 111In‐labelled platelet scan as a predictor of splenectomy outcome in ITP.
47. Contributors
48. Pregnancy loss and thrombophilia: the elusive link.
49. Transcriptional Repression of Peri-Implantation EMX2 Expression in Mammalian Reproduction by HOXA10.
50. Maternal Hoxa10 is required for pinopod formation in the development of mouse uterine receptivity to embryo implantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.